Study period | ||||||||
---|---|---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close-out | |||||
Timepoint | − t1 | 0 | t1 | t2 | t3 | t4 | t5 | tx |
Enrollment: | ||||||||
Vitals | X | |||||||
Informed consent | X | |||||||
Allocation | X | |||||||
INTERVENTIONS: | ||||||||
TMS (anodal, cathodal, sham, or bilateral) | X | |||||||
Washout | X | |||||||
Assessments: | ||||||||
TMS | X | X | ||||||
FM-UE | X | X | X | |||||
MAS | X | X | ||||||
Monitor 10–15 min for adverse effects | X |